Welcome to our dedicated page for ENSIGN GROUP SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (ENSG) filings document its public-company reporting as a Delaware healthcare services company with common stock listed on the Nasdaq Global Select Market. Its disclosures cover skilled nursing and senior living operations, therapy and rehabilitative services, healthcare real estate, and the Standard Bearer real estate segment.
Ensign’s 8-K reports disclose quarterly and annual operating results and Regulation G non-GAAP measures, including adjusted net income, adjusted earnings per share, EBITDA, adjusted EBITDA, adjusted EBITDAR, adjusted EBT, and Funds from Operations for its real estate segment. Proxy materials cover shareholder voting, board governance, executive compensation, equity awards, capital-structure matters, and other governance disclosures.
ENSG filed a Form 144 notice for a planned sale of 146 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of 26033.26. These shares are part of a class with 57924783 shares outstanding and are expected to be sold around 01/21/2026. The securities were acquired on 01/17/2026 via restricted stock vesting from the issuer as compensation.
The person named in the recent sale history, John Agwunobi, previously sold 246 common shares on 11/06/2025 for gross proceeds of 46462.02 and another 246 shares on 01/20/2026 for gross proceeds of 44235.72. This notice also confirms the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.
Ensign Group, Inc. director and CFO Suzanne Snapper filed an amended Form 4 to correct how a prior stock gift was reported. A November 7, 2025 gift of 2,675 shares of common stock had previously been shown as coming from her direct holdings. This amendment clarifies that the gifted shares were held indirectly through a trust rather than directly.
Following the corrected reporting, Snapper is shown as owning 269,204 shares of Ensign Group common stock directly and 56,340 shares indirectly, held by the Eric and Suzanne Snapper Family Trust, of which she and her spouse are trustees. The transaction was a gift reported at a price of $0 per share and does not reflect a market sale.
Ensign Group, Inc. director Barry M. Smith reported an equity award of 600 shares of common stock on January 15, 2026, at a grant price of $0 per share. After this award, he beneficially owns 24,252 shares of Ensign Group common stock directly. The 600 granted shares are subject to vesting in three equal annual installments beginning on January 15, 2027, meaning they become fully his over a three-year period if vesting conditions are met.
The Ensign Group director reports a new stock grant. Director Daren Shaw received an award of 600 shares of Ensign Group common stock on January 15, 2026 at a price of $0 per share. Following this award, he beneficially owns 24,726 common shares directly.
The grant is subject to a multi-year vesting schedule. The 600 shares vest in three equal annual installments beginning January 15, 2027, meaning one-third of the award becomes fully owned each year over three years.
The Ensign Group director reports a new stock award. Director Ann Scott Blouin acquired 600 shares of Ensign Group common stock on January 15, 2026 in a transaction reported at a price of $0 per share, indicating a share grant rather than a market purchase. After this award, she beneficially owns 23,227 Ensign Group shares in direct ownership.
The filing notes that these 600 shares vest in three equal annual installments beginning January 15, 2027, so the director will earn the shares over time rather than receiving them all at once.
The Ensign Group director Abbott Swati Bargotra reported receiving 600 shares of common stock of The Ensign Group, Inc. on January 15, 2026 in a Form 4 filing. The shares were acquired at a stated price of $0 per share, indicating they were granted as equity compensation rather than purchased on the market. Following this award, Bargotra beneficially owns 19,632 shares of Ensign common stock in total. According to the footnote, these 600 shares vest in three equal annual installments beginning on January 15, 2027, meaning the director earns the shares over time, subject to the vesting schedule.
The Ensign Group director receives stock grant
Director John O. Agwunobi reported an award of 600 shares of Ensign Group common stock on January 15, 2026, at a stated price of $0 per share, indicating a stock-based compensation grant rather than an open-market purchase. After this grant, he beneficially owns 9,479.149 shares directly.
The footnote explains that these 600 shares are subject to a vesting schedule, vesting in three equal annual installments beginning January 15, 2027, which spreads the compensation over time and ties it to continued service.
The Ensign Group director reports new stock award. Director Mark Vincent Parkinson reported receiving 600 shares of The Ensign Group, Inc. common stock on January 15, 2026, recorded at a price of $0 per share, indicating an equity grant rather than a market purchase. After this award, he beneficially owns 3,000 shares of common stock in total.
The 600-share award is structured to vest over time, with the shares vesting in three equal annual installments beginning on January 15, 2027. This staged vesting schedule ties the director’s equity compensation to continued service with the company.
A shareholder has filed a Rule 144 notice for a planned sale of 246 shares of common stock, to be executed through Fidelity Brokerage Services LLC on the NASDAQ. The filing lists an aggregate market value of 44,235.72 for these shares and states that the approximate sale date is 01/20/2026.
The 246 shares to be sold were acquired via restricted stock vesting from the issuer as compensation, with 100 shares vesting on 01/15/2026 and 146 shares on 01/16/2026. The notice also references a prior sale by the same person of 246 common shares on 11/06/2025 for gross proceeds of 46,462.02.
The Ensign Group, Inc. reported an insider stock transaction by its VP and Chief Legal Officer. On December 12, 2025, the officer exercised 2,500 employee stock options at an exercise price of $44.84 per share, acquiring the same number of common shares.
On the same date, the officer sold 1,000, 5,846 and 1,554 shares of common stock at weighted average sale prices of $174.1075, $175.516 and $176.207, respectively, leaving 32,779 common shares owned directly after the transactions and no remaining derivative securities. The activity was effected under a Rule 10b5-1 trading plan adopted on September 2, 2025, using options originally granted on May 28, 2020 that vest over five equal annual installments.